All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0729 | Anti-CYP2C9 (CBXC-2839) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2839 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4153 | Anti-CYP2C9 (CBXC-2839) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2839 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3060 | Anti-CYP2C9 (CBFYC-2573) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2573 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6313 | Anti-CYP2C9 (CBFYC-2573) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2573 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0732 | Anti-CYP2C9 (CBWJC-3556) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3556 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0733 | Anti-CYP2C9 (CBWJC-3557) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3557 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0734 | Anti-CYP2C9 (CBWJC-3558) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3558 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ3024 | Anti-CYP2C9 (CBWJC-3556) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3556 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ3025 | Anti-CYP2C9 (CBWJC-3557) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3557 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ3026 | Anti-CYP2C9 (CBWJC-3558) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3558 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION